541 related articles for article (PubMed ID: 18288733)
61. Percutaneous occlusion of patent foramen ovale in patients with paradoxical embolism.
Pinto FF; Sousa L; Abreu J; Agapito A; Quininha J; Kaku S; Antunes AM
Rev Port Cardiol; 2001; 20(7-8):747-57; discussion 759-62. PubMed ID: 11582625
[TBL] [Abstract][Full Text] [Related]
62. Management of residual shunts after initial percutaneous patent foramen ovale closure: a single center experience with immediate and long-term follow-up.
Diaz T; Cubeddu RJ; Rengifo-Moreno PA; Cruz-Gonzalez I; Solis-Martin J; Buonanno FS; Inglessis I; Palacios IF
Catheter Cardiovasc Interv; 2010 Jul; 76(1):145-50. PubMed ID: 20578100
[TBL] [Abstract][Full Text] [Related]
63. CardioSEAL/STARflex versus Amplatzer devices for percutaneous closure of small to moderate (up to 18 mm) atrial septal defects.
Butera G; Carminati M; Chessa M; Delogu A; Drago M; Piazza L; Giamberti A; Frigiola A
Am Heart J; 2004 Sep; 148(3):507-10. PubMed ID: 15389240
[TBL] [Abstract][Full Text] [Related]
64. Percutaneous closure of patent foramen ovale and valvular function -- effect of the amplatzer occluder.
Krasniqi N; Roth J; Siegrist PT; Toggweiler S; Gruner C; Greutmann M; Tanner FC; Lüscher TF; Corti R
J Invasive Cardiol; 2012 Jun; 24(6):274-7. PubMed ID: 22684381
[TBL] [Abstract][Full Text] [Related]
65. Long-Term Contrast Echocardiography and Clinical Follow-Up after Percutaneous Closure of Patent Foramen Ovale Using Two Different Atrial Septal Occluder Devices.
Scalise F; Auguadro C; Sorropago G; Sorropago A; Novelli E; Finizio M; Specchia G
J Interv Cardiol; 2016 Aug; 29(4):406-13. PubMed ID: 27338839
[TBL] [Abstract][Full Text] [Related]
66. Technology Insight: transcatheter closure of ventricular septal defects.
Moodie DS
Nat Clin Pract Cardiovasc Med; 2005 Nov; 2(11):592-6. PubMed ID: 16258571
[TBL] [Abstract][Full Text] [Related]
67. Transcatheter PFO closure with GORE(®) septal occluder: early and mid-term clinical results.
Butera G; Saracino A; Danna P; Sganzerla P; Chessa M; Carminati M
Catheter Cardiovasc Interv; 2013 Nov; 82(6):944-9. PubMed ID: 23897659
[TBL] [Abstract][Full Text] [Related]
68. Anatomy of the patent foramen ovale for the interventionalist.
McKenzie JA; Edwards WD; Hagler DJ
Catheter Cardiovasc Interv; 2009 May; 73(6):821-6. PubMed ID: 19330826
[TBL] [Abstract][Full Text] [Related]
69. Clinical Performance of the New Gore Septal Occluder in Patent Foramen Ovale Closure: A Single-Center Experience.
Sganzerla P; Rondi M; Pavone A; Aiolfi E; Facchinetti A; Funaro A; Negrini P
J Invasive Cardiol; 2015 Sep; 27(9):430-4. PubMed ID: 26332878
[TBL] [Abstract][Full Text] [Related]
70. Residual shunt after percutaneous closure of patent foramen ovale with AMPLATZER occluder devices - influence of anatomic features: a transcranial Doppler and intracardiac echocardiography study.
Marchese N; Pacilli MA; Inchingolo V; Fanelli R; Loperfido F; Vigna C
EuroIntervention; 2013 Jul; 9(3):382-8. PubMed ID: 23872652
[TBL] [Abstract][Full Text] [Related]
71. Transcatheter closure of atrial septal defect with Amplatzer device in children aged less than 10 years old: immediate and late follow-up.
Rossi RI; Cardoso Cde O; Machado PR; Francois LG; Horowitz ES; Sarmento-Leite R
Catheter Cardiovasc Interv; 2008 Feb; 71(2):231-6. PubMed ID: 17985387
[TBL] [Abstract][Full Text] [Related]
72. Figulla PFO occluder versus Amplatzer PFO occluder for percutaneous closure of patent foramen ovale.
Saguner AM; Wahl A; Praz F; de Marchi SF; Mattle HP; Cook S; Windecker S; Meier B
Catheter Cardiovasc Interv; 2011 Apr; 77(5):709-14. PubMed ID: 20931665
[TBL] [Abstract][Full Text] [Related]
73. Is routine ultrasound guidance really necessary for closure of patent foramen ovale using the Amplatzer PFO occluder?
Fateh-Moghadam S; Steeg M; Dietz R; Bocksch W
Catheter Cardiovasc Interv; 2009 Feb; 73(3):361-6. PubMed ID: 19133676
[TBL] [Abstract][Full Text] [Related]
74. Gore Helex septal occluder for percutaneous closure of patent foramen ovale associated with atrial septal aneurysm: short- and mid-term clinical and echocardiographic outcomes.
Musto C; Cifarelli A; Fiorilli R; De Felice F; Parma A; Pandolfi C; Confessore P; Bernardi L; Violini R
J Invasive Cardiol; 2012 Oct; 24(10):510-4. PubMed ID: 23043034
[TBL] [Abstract][Full Text] [Related]
75. Initial clinical experience with the GORE septal occluder for the treatment of atrial septal defects and patent foramen ovale.
Freixa X; Ibrahim R; Chan J; Garceau P; Dore A; Marcotte F; Mercier LA; Mongeon FP; Basmadjian A; Khairy P; Asgar AW
EuroIntervention; 2013 Sep; 9(5):629-35. PubMed ID: 24058079
[TBL] [Abstract][Full Text] [Related]
76. Transseptal puncture to facilitate device closure of "long-tunnel" patent foramen ovale.
Thompson AJ; Hagler DJ; Taggart NW
Catheter Cardiovasc Interv; 2015 May; 85(6):1053-7. PubMed ID: 25380406
[TBL] [Abstract][Full Text] [Related]
77. Transcatheter closure of patent foramen ovale without an implant: initial clinical experience.
Sievert H; Fischer E; Heinisch C; Majunke N; Roemer A; Wunderlich N
Circulation; 2007 Oct; 116(15):1701-6. PubMed ID: 17893276
[TBL] [Abstract][Full Text] [Related]
78. The BioSTAR(r) device versus the CardioSEAL(r) device in patent foramen ovale closure: comparison of mid-term efficacy and safety.
Van den Branden BJ; Luermans JG; Post MC; Plokker HW; Ten Berg JM; Suttorp MJ
EuroIntervention; 2010 Sep; 6(4):498-504. PubMed ID: 20884438
[TBL] [Abstract][Full Text] [Related]
79. Clinical evaluation of a novel occluder device (Occlutech) for percutaneous transcatheter closure of patent foramen ovale (PFO).
Krizanic F; Sievert H; Pfeiffer D; Konorza T; Ferrari M; Figulla HR
Clin Res Cardiol; 2008 Dec; 97(12):872-7. PubMed ID: 18696022
[TBL] [Abstract][Full Text] [Related]
80. Safety and feasibility of day case patent foramen ovale (PFO) closure facilitated by intracardiac echocardiography.
Ponnuthurai FA; van Gaal WJ; Burchell A; Mitchell AR; Wilson N; Ormerod OJ
Int J Cardiol; 2009 Jan; 131(3):438-40. PubMed ID: 18037512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
